Earkart Limited Secures ₹2.77 Crore Government Contract Through GeM Portal

Earkart Limited has announced the successful award of a government contract valued at ₹2.77 crores through the Government e-Marketplace (GeM) portal. The healthcare sector company disclosed this development on January 14, 2026, in compliance with Regulation 30 of SEBI (LODR) Regulations, 2015.

Contract Details and Specifications

The order has been awarded by Artificial Limbs Manufacturing Corporation of India (ALIMCO), a government entity, for the supply of TLM Kits (LG95). This domestic supply contract represents a significant business opportunity for the company in the healthcare equipment segment.

Parameter:	Details
Awarding Entity:	Artificial Limbs Manufacturing Corporation of India (ALIMCO)
Contract Value:	₹2,76,55,844.00
Product:	TLM Kits (LG95)
Contract Type:	Supply contract (Government)
Duration:	One time contract
Market:	Domestic

Financial Impact and Compliance

The contract worth ₹2,76,55,844.00 (Rupees Two Crore Seventy-Six Lakhs and Fifty-five Thousand Eight Hundred Forty-four only) is expected to contribute positively to Earkart Limited's revenue during the contract execution period. The company has confirmed that this represents a one-time supply engagement with the government entity.

Regulatory Disclosures

Earkart Limited has made comprehensive disclosures regarding the contract award, confirming several key compliance aspects:

No promoter, promoter group, or group companies have any interest in ALIMCO
The contract does not fall within related party transactions
All disclosure requirements under SEBI regulations have been met
The award was made through the transparent GeM portal system

The company, through Company Secretary Preeti Srivastava, has submitted this information to BSE Limited under the mandatory disclosure requirements. This government contract award demonstrates Earkart Limited's capability to secure institutional orders in the healthcare equipment sector and reinforces its position in the domestic market for specialized medical supplies.

Earkart Limited's board of directors conducted a comprehensive review of a proposed investment opportunity during their meeting on December 18, 2025. The board session, which ran from 11:00 AM to 12:40 PM, focused entirely on the company's potential investment in Turtle Maarks LLP.

Board Meeting Details

The meeting outcome was communicated to BSE Limited in compliance with SEBI regulations. Key details of the board session include:

Parameter	Details
Meeting Date	Thursday, December 18, 2025
Commencement Time	11:00 AM
Conclusion Time	12:40 PM
Primary Agenda	Turtle Maarks LLP Investment Discussion
Regulatory Compliance	Regulations 30, 33, and 42

Investment Review Authorization

Following detailed deliberations, the board authorized a comprehensive review of the investment proposal. An Independent Director has been tasked with conducting this evaluation, which will include undertaking fresh valuation parameters and comprehensive due diligence of Turtle Maarks LLP.

Next Steps and Timeline

The board has established a timeline for the investment review process. The Independent Director is expected to present detailed findings and recommendations at the next scheduled board meeting on Tuesday, December 23, 2025. At this meeting, directors will review the comprehensive analysis before making any final investment decisions.

Regulatory Compliance

Earkart Limited has fulfilled its disclosure obligations under the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company's communication to BSE Limited ensures transparency regarding this corporate development and maintains compliance with applicable listing regulations.